A detailed history of Sherbrooke Park Advisers LLC transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 18,556 shares of CDMO stock, worth $228,238. This represents 0.05% of its overall portfolio holdings.

Number of Shares
18,556
Holding current value
$228,238
% of portfolio
0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.7 - $12.45 $124,325 - $231,022
18,556 New
18,556 $211 Million
Q4 2023

Feb 14, 2024

BUY
$4.64 - $9.56 $82,244 - $169,451
17,725 New
17,725 $115 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $765M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.